577 related articles for article (PubMed ID: 26375765)
1. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
2. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the fetal hemoglobin silencing factor BCL11A.
Basak A; Sankaran VG
Ann N Y Acad Sci; 2016 Mar; 1368(1):25-30. PubMed ID: 26963603
[TBL] [Abstract][Full Text] [Related]
4. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
5. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencing of fetal hemoglobin by BCL11A.
Sankaran VG; Xu J; Orkin SH
Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
[TBL] [Abstract][Full Text] [Related]
8. Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
Weber L; Frati G; Felix T; Hardouin G; Casini A; Wollenschlaeger C; Meneghini V; Masson C; De Cian A; Chalumeau A; Mavilio F; Amendola M; Andre-Schmutz I; Cereseto A; El Nemer W; Concordet JP; Giovannangeli C; Cavazzana M; Miccio A
Sci Adv; 2020 Feb; 6(7):. PubMed ID: 32917636
[TBL] [Abstract][Full Text] [Related]
9. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
11. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.
Menzel S; Garner C; Gut I; Matsuda F; Yamaguchi M; Heath S; Foglio M; Zelenika D; Boland A; Rooks H; Best S; Spector TD; Farrall M; Lathrop M; Thein SL
Nat Genet; 2007 Oct; 39(10):1197-9. PubMed ID: 17767159
[TBL] [Abstract][Full Text] [Related]
12. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
Solovieff N; Milton JN; Hartley SW; Sherva R; Sebastiani P; Dworkis DA; Klings ES; Farrer LA; Garrett ME; Ashley-Koch A; Telen MJ; Fucharoen S; Ha SY; Li CK; Chui DH; Baldwin CT; Steinberg MH
Blood; 2010 Mar; 115(9):1815-22. PubMed ID: 20018918
[TBL] [Abstract][Full Text] [Related]
13. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
14. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
[TBL] [Abstract][Full Text] [Related]
16. [BCL11A controls the expression of the human fetal hemoglobin].
Labie D
Med Sci (Paris); 2012 Nov; 28(11):923-5. PubMed ID: 23171892
[No Abstract] [Full Text] [Related]
17. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
[TBL] [Abstract][Full Text] [Related]
18. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
[TBL] [Abstract][Full Text] [Related]
19. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
20. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
